CIK 0001819411 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Gain Therapeutics, Inc.
Sign in to watch- Ticker
- GANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851726310
- Phone
- (301) 500-1556
- Business address
- 4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-25 | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER | Purchase | +2,482 | $2.58 | $6K | 217,729 |
| 2022-05-20 | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER | Purchase | +9,256 | $2.83 | $26K | 215,247 |
| 2022-05-19 | RICHMAN ERIC I CHIEF EXECUTIVE OFFICER | Purchase | +4,000 | $2.71 | $11K | 205,991 |
| 2022-05-19 | Calabrese Salvatore CHIEF FINANCIAL OFFICER | Purchase | +3,000 | $2.70 | $8K | 3,000 |
| 2022-05-19 | Calabrese Salvatore CHIEF FINANCIAL OFFICER | Purchase | +3,000 | $8,100.00 | $24.3M | |
| 2021-12-23 | Alder Matthias CHIEF OPERATING OFFICER | Grant or award · Non Qualified Stock Option (right to buy) | +200,000 | $5.86 | $1.2M | 200,000 |
| 2021-08-16 | RICHMAN ERIC I Chief Executive Officer | Purchase | +4,922 | $7.87 | $39K | 216,820 |
| 2021-08-16 | RICHMAN ERIC I Director | Option exercise | +4,922 | $7.87 | $39K | 216,820 |
Page 5 of 5 · 88 trades